Fundraising Fox

Sun Altbach

Investor

Senior Advisor BOLD Longevity at Bold Capital Partners

Boston, Massachusetts, United States

About

Sun Altbach is a life sciences executive, board director, and strategist with over 20 years of experience in the global biopharma industry, having worked with private early-stage companies as well as publicly listed firms. Altbach's areas of work include company formation, seed and equity financing, drug development, regulatory submission, preclinical execution, commercial readiness, and portfolio management across multiple therapeutic areas. Altbach currently serves as Senior Scientific Advisor at BOLD Longevity Growth Fund.

Experience

  1. BOLD Longevity Growth FundSenior Scientific Advisorcurrent2023 — present
  2. Franklin Cummings TechBiotech Industry Advisory Board Membercurrent2025 — present
  3. Termeer InstituteAdvisory Board Membercurrent2020 — presentMarblehead, MA
  4. Women In Bio - Engage. Educate. Empower.Board-ready program 2021current2021 — present
  5. Longevity Vision FundSenior Scientific Advisor2021 — 2023
  6. PIC TherapeuticsCEO, President and Board Member2018 — 2020Boston, MA
  7. CrestovoVice President of Program Management and Operations2017 — 2018Cambridge, MA
  8. OvaScienceSenior Director, Global Technical Development and Operations2015 — 2017London, United Kingdom
  9. Shire PharmaceuticalsHead, Research and Nonclinical Development Operations2012 — 2014
  10. Sanofi GenzymeProgram and Portfolio Management2004 — 2010
  11. BiogenIdecMedical Affairs2000 — 2004
  12. Beth Israel Deaconess Medical CenterDepartment of Medicine1998 — 2000Boston

Skills & more

Lifesciences12Pharmaceutical Industry14Clinical Development18Technology Transfer4Oncology6Clinical Trials7Drug Development16Cross-functional Team Leadership9FDA3Drug Discovery2Product Management6Program Management3
+6 moreProduct DevelopmentBiotechnologyMedical AffairsBiopharmaceuticalsCommercializationLife Sciences

From Sun's professional profile.

Colleagues at Bold Capital Partners

Avik Arakelian
Partner BOLD Longevity at Bold Capital Partners
Daglar Cizmeci
Venture Partner at Bold Capital Partners
Emilio Diez Barroso
General Partner at Bold Capital Partners
Felicia Hsu
Principal at Bold Capital Partners
Gunner Hardy
Associate BOLD Longevity at Bold Capital Partners
Helen McBride
Partner at Bold Capital Partners
Henry Shi
Venture Partner at Bold Capital Partners
Kris Verburgh
Partner BOLD Longevity at Bold Capital Partners

Frequently asked questions

Who is Sun Altbach?
Sun Altbach is a life sciences executive, board director, and strategist with over 20 years of experience in the global biopharma industry, having worked with private early-stage companies as well as publicly listed firms. Altbach's areas of work include company formation, seed and equity financing, drug development, regulatory submission, preclinical execution, commercial readiness, and portfolio management across multiple therapeutic areas. Altbach currently serves as Senior Scientific Advisor at BOLD Longevity Growth Fund.
Where does Sun Altbach work?
Sun Altbach is Senior Advisor BOLD Longevity at Bold Capital Partners.
Where did Sun Altbach go to school?
Sun Altbach studied at MIT Sloan School of Management (MBA); Smith College (BA).

Same school

Also attended MIT Sloan School of Management518

Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor

+ 512 more

Also attended Smith College26

Natasha SharmaInvestor at True VenturesNigel CarrDirector at Acario InnovationSu FuAffiliate at ARCH Venture PartnersLeah PalmerManaging Director and General Counsel at Spectrum EquitySun AltbachSenior Scientific Advisor at BOLD LongevityLaurel ToubyManaging Partner at Supernode Ventures

+ 20 more

Shared employers

Also worked at Women In Bio - Engage. Educate. Empower.3

Chaya PatelPrincipal at Mission BiocapitalSun AltbachSenior Scientific Advisor at BOLD LongevityMonica BerrondoPhD at Brazen Capital

Also worked at Longevity Vision Fund7

Sergey YoungCo-Founder at BOLD LongevityKris VerburghPartner & Head of Science at BOLD LongevitySun AltbachSenior Scientific Advisor at BOLD LongevityGunner HardyAssociate at BOLD LongevitySergey YoungCo-Founder BOLD Longevity at Bold Capital PartnersKris VerburghPartner BOLD Longevity at Bold Capital Partners

+ 1 more

Also worked at Shire Pharmaceuticals13

Sun AltbachSenior Scientific Advisor at BOLD LongevityJulie KimRepresentative Director – President and CEO at Takeda VenturesGabriele RicciChief Data & Technology Officer at Takeda VenturesRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesJeffrey M. JonasPartner at Cure VenturesSusan KilsbyAdvisor at Siddhi Capital

+ 7 more

Also worked at Sanofi Genzyme95

Walter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE VenturesWalter OlesiakOperating Partner at RDiscovery

+ 89 more